Position in PFE
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$24,652,381
-$4,294,027 QoQ
Shares Held
1,023,770
-0.7% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
3.47%
of 13F equity value
Holder Rank
#247
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nexus Investment Management ULC holds $61,054,403 across 9 Drug Manufacturers - General names. PFE ranks #2 (40.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
251,016 | $31,713,361 | |
| 2 | PFE |
Pfizer Inc
This page
|
1,023,770 | $24,652,381 | |
| 3 | JNJ |
Johnson & Johnson
|
8,381 | $2,128,522 | |
| 4 | LLY |
ELI LILLY & Co
|
769 | $922,361 | |
| 5 | ABBV |
AbbVie Inc.
|
3,456 | $869,667 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,735 | $479,947 | |
| 7 | BIIB |
Biogen Inc.
|
920 | $198,775 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
953 | $54,911 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,652,381 | 1,023,770 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $28,946,408 | 1,030,855 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $24,681,502 | 991,225 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $24,754,457 | 971,525 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $21,211,139 | 875,047 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $21,965,649 | 866,837 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $21,709,154 | 818,287 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $23,291,259 | 804,812 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $22,391,190 | 800,257 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $23,139,226 | 833,846 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $21,401,795 | 743,376 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $24,597,246 | 741,551 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $26,986,613 | 735,731 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $29,783,632 | 729,991 | Shares | Sole | 2023-04-04 | |
| 2022-12-31 | $36,469,608 | 711,741 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $30,981,729 | 707,992 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $36,809,372 | 702,067 | Shares | Sole | 2022-07-06 | |
| 2022-03-31 | $39,510,967 | 763,202 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $45,679,426 | 773,572 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $33,208,967 | 772,122 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $30,497,808 | 778,800 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $28,189,657 | 778,075 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $27,306,578 | 741,825 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $26,591,876 | 724,575 | Shares | Sole | 2020-10-05 | |
| 2020-06-30 | $23,603,701 | 721,825 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $23,302,480 | 713,925 | Shares | Sole | 2020-04-03 | |
| No filing history on record for this holder in this stock. | ||||||